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Summary: Tissue-specific expression of cre recombi-
nase is a well-established genetic tool to analyze gene
function, and it is limited only by the efficiency and
specificity of available cre mouse strains. Here, we
report the generation of a transgenic line containing a
cre cassette with codon usage optimized for mamma-
lian cells (iCre) under the control of a mouse glycopro-
tein hormone a-subunit (aGSU) regulatory sequences in
a bacterial artificial chromosome genomic clone. Initial
analysis of this transgenic line, Tg(aGSU-iCre), with cre
reporter strains reveals onset of cre activity in the dif-
ferentiating cells of the developing anterior pituitary
gland at embryonic day 12.5, with a pattern characteris-
tic of endogenous aGSU. In adult mice, aGSU-iCre was
active in the anterior lobe of the pituitary gland and in
the cells that produce aGSU (gonadotropes and thyro-
tropes) with high penetrance. Little or no activity was
observed in other tissues, including skeletal and car-
diac muscle, brain, kidney, lungs, testis, ovary, and liver.
This aGSU-iCre line is suitable for efficient, specific,
and developmentally regulated deletion of floxed alleles
in anterior pituitary gonadotropes and thyrotropes.
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INTRODUCTION
During the development of the mammalian anterior
pituitary gland, the distinct hormone-producing cell
types emerge and organize into networks (Budry et al.,
2011; Davis et al., 2011). Initially, precursor cells prolif-
erate and differentiate into five different endocrine cell
types that are typified by the hormones that they pro-
duce: corticotropes produce adrenocorticotropin
(ACTH), thyrotropes produce thyroid stimulating hor-
mone (TSH), somatotropes produce growth hormone
(GH), lactotropes produce prolactin (PRL), and gonado-
tropes produce luteinizing hormone (LH) and follicle-
stimulating hormone (FSH). In mouse embryonic devel-
opment, hormone producing cell types become detect-
able over a period spanning embryonic days 12.5
(e12.5) to e17.5 (Japon et al., 1994). Genetic and bio-
chemical studies have identified several of the transcrip-
tion factors that are crucial for cell lineage
determination and differentiation and cell-specific hor-
monal gene expression (Marcil A et al., 2003) [rev in
(Zhu and Rosenfeld, 2004)]. Both gonadotropes and
thyrotropes express a common a-glycoprotein subunit
(aGSU), which heterodimerizes with separate b-
subunits of the glycoprotein hormones, LH, FSH, and
TSH, to give the biologically active hormones. aGSU is
the first pituitary hormone component detected during
development. The earliest detectable signal is present
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at e11.5 in the rostral and ventral most region of
Rathke’s pouch (Burrows et al., 1996). Deletion of this
gene, officially known as chorionic gonadotropin alpha
or Cga, revealed that it is necessary after birth for stimu-
lation of thyroid and gonadal growth and function (Ken-
dall et al., 1991).
The cre-loxP system has become a powerful tool to
study the effects of gene deletion in a particular cell
type or tissue, especially when conventional gene tar-
geting by homologous recombination in embryonic
stem cells results in an early lethal phenotype. To study
the pituitary specific effects of gene deletion, we previ-
ously generated transgenic mice that express the cre
recombinase under the transcriptional control of the
mouse aGSU gene (Cga). A sequence of 4.6 kb of the
mouse aGSU gene promoter and enhancer (B6;SJL-
Tg(Cga-cre)3Sac/J) targets the gonadotropes and thyro-
tropes, as well as the other hormone-producing cells of
the adult anterior pituitary gland (Cushman et al.,
2000). These sequences are sufficient to confer devel-
opmentally regulated and hormone-responsive gene
expression in the pituitary gland, and they have been
used successfully to create pituitary-specific deletions
of several genes (Bliss et al., 2009; Charles et al., 2006;
Cushman et al., 2000; Kendall et al., 1994). Ectopic cre
activity, however, is observed in the ovary and in the
skeletal and cardiac muscle of 4.6 kb aGSU transgenic
mice, limiting the usefulness of this transgene for some
purposes (Uhlenhaut et al., 2009).
To generate aGSU-Cre transgenic mice that more
accurately recapitulate endogenous aGSU gene expres-
sion, we used homologous recombination in E. coli to
introduce improved cre recombinase (iCre) coding
sequences into a bacterial artificial chromosome (BAC)
containing the mouse aGSU gene. A transgenic line car-
rying this construct conferred highly penetrant cre
mediated excision of floxed reporter genes and had
minimal ectopic expression. This suggests that regula-
tory DNA sequences present in the BAC confer more
accurate aGSU gene expression than promoter-
proximal sequences alone.
RESULTS AND DISCUSSION
Cga, a single gene in the mouse genome, encodes
aGSU, and is flanked by Zfp292 and Mobkl2b on
mouse chromosome 4. Using recombineering in E. coli,
we inserted an improved cre expression cassette (iCre)
into a 228 kb mouse aGSU genomic BAC clone in exon
1 at the translation start site (Fig. 1). The iCre has
reduced CpG content relative to the prokaryotic coding
sequence, thereby reducing the chances of epigenetic
silencing in mammals (Shimshek et al., 2002). The engi-
neered BAC was injected into the pronucleus of fertil-
ized eggs from a C57BL/6J cross with B6D2F1 mice to
generate aGSU-iCre BAC transgenic mice. We identified
a founder transgenic mouse containing the complete
BAC using polymerase chain reaction (PCR) genotyping
with primers for the iCre insertion and the BAC vector
backbone. This line Tg(Cga-iCre)Sac961 is referred to
here as aGSU-iCre for simplicity.
We determined that the transgene does not affect the
expression levels of endogenous aGSU using quantitative
PCR (data not shown). To asses the specificity, efficiency,
and in vivo activity of the aGSU-iCre BAC transgene,
transgenic mice were crossed with two different cre-
reporter transgenic mice that express a reporter gene
only after excision of a floxed stop sequence: Rosa
26-LacZ and Rosa26-EYFP (officially B6;129S4-Gt(ROSA)
26Sortm1Sor/J and B6.Cg-Gt(ROSA)26Sortm2(CAG-EYFP)Hze/J
FIG. 1. Structure of the BAC Tg(aGSU-iCre) transgene. The position of the aGSU gene within the RP24–329P6 BAC is indicated, together
with Zfp292 (80 kb) and a portion of the Mobkl2b gene (60 kb/from 208 kb). The exon-intron structure of the aGSU gene is shown. The first
exon is noncoding (light blue) and four exons are coding (blue rectangles). The recombination targeted the second aGSU exon, inserting the
iCre coding sequence at the ATG of the aGSU gene and using the aGSU gene polyadenylation sequence. The 4.6 kb promoter used for the
previous aGSU-Cre transgenic mouse is indicated.
786 PEREZ-MILLAN ET AL.
respectively). Both aGSU-iCre female and male mice
were fertile.
The DNA recombination pattern in the developing
pituitary and adult tissues was analyzed by crossing
aGSU-iCre mice with the Rosa26-LacZ cre reporter line
(Friedrich and Soriano, 1991; Soriano, 1999; Zambro-
wicz et al., 1997). In transgenic animals carrying both
Rosa26-LacZ and aGSU-iCre transgenes, the Cre recom-
binase catalyzed the removal of the stop sequence, lead-
ing to b-galactosidase production. X-Gal stained aGSU-
iCre;Rosa26LacZ double transgenic embryos showed
that recombination occurred in the developing pitui-
tary gland at embryonic day 11.5 (e11.5), in a few cells
(data not shown). This is consistent with the develop-
mental timing of endogenous aGSU expression (Ken-
dall et al., 1991). By e12.5 essentially all of the cells at
the ventral aspect of the pouch are stained, with a pat-
tern of expression characteristic of endogenous aGSU
expression (Fig. 2). Little or no staining was detected in
the bodies of whole mount stained embryos, while the
4.6 kb aGSU-cre transgene was active in the somites at
e12.5 and other ectopic sites (Cushman et al., 2000).
After removing the mandible, transgene activity is
obvious in the developing pituitary gland and in other
areas that express endogenous aGSU: the mesenchyme
adjacent to the eye and the olfactory epithelium (Ken-
dall et al., 1991). Sagittal sections revealed X-gal stain-
ing confined to the expected rostral, ventral area of
Rathke’s pouch where differentiated cells expressing
aGSU are appearing. At e11.5 limited b-galactosidase
activity was detected (data not shown) (Cushman et al.,
2000). This is consistent with the developmental timing
of endogenous aGSU expression (Kendall et al., 1991).
These results show that the new aGSU-iCre BAC trans-
genic mouse line mediates recombination much more
specifically than the previous line using only 4.6 kb of
regulatory sequences.
The tissue specificity of the aGSU-iCre transgene was
analyzed by X-Gal staining of cryosections from adult
tissues (2 mo old) from aGSU-iCre; Rosa26LacZ double
transgenic mice. Cre transgene activity was detected in
the pituitary of 2 mo old adult mice, with no activity in
inappropriate tissues such as muscle, kidney, lung, tes-
tis, and liver (Fig. 3). A few rare, positive cells were
detected in the brain, and low levels of activity were
noted in some follicles of the ovary (Fig. 3). Because of
the potential for multiple organs in the hypothalamic-
pituitary-gonadal axis to be affected in gene deletion
studies using the aGSU-icre, we characterized
Cre expression in the ovary using a different reporter
mouse, Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J,
which switches from red fluorescent tdTomato to green
fluorescent eGFP upon recombination. Only a few scat-
tered cells in some, but not all ovaries, were detected
using either reporter mouse. Although this may affect
the results of gene deletion, if the gene of interest is
expressed in the ovary, the aGSU-iCre BAC transgenic
line greatly improves pituitary specificity over previ-
ously available reagents and more accurately reflects
the expression of the endogenous aGSU gene.
To study the pituitary cell specificity, the aGSU-iCre
transgenic mice were crossed with Rosa26-EYFP cre
reporter line. In this reporter mouse line, cre excision
of the loxP-flanked STOP fragment permits EYFP gene
expression (Madisen et al., 2010) that can be detected
by antibody staining against EGFP. Cell specificity was
assessed by following EGFP immunohistochemistry
(IHC) with staining for individual antibodies specific to
each of the pituitary hormones (aGSU, TSHb, LHb,
FSHb, GH, PRL, and ACTH). IHC on pituitary cryosec-
tions from aGSU-iCre; Rosa26EYFP double transgenic
mice reveals high levels of aGSU-iCre activity in the
anterior lobe of the pituitary, with no expression in the
intermediate and posterior lobe (Fig. 4A). Double IHC
FIG. 2. Expression of the BAC Tg(aGSU-iCre) transgene in the developing pituitary gland at e12.5. X-Gal stained aGSU-iCre; Rosa26LacZ
double transgenic embryos reveal activity of the aGSU-iCre transgene during development. Panel A: Whole X-gal stained double transgenic
embryo (e12.5). Panel B: The mandible was removed from the embryo in panel A to visualize the pituitary (arrow). Panel C: Sagittal cryosec-
tion of X-gal stained double transgenic embryo showing expression in the forming anterior lobe of the pituitary. Section is counterstained
with neutral red. Magnification bar represents 100 mm.
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for eGFP and aGSU reveals that most aGSU positive
cells undergo cre recombination (Fig. 4B). Quantitation
of hormone positive cells for EGFP expression revealed
a high level of penetrance in gonadotropes and thyro-
tropes with a low level of expression in other pituitary
cell types (Fig. 5, Table 1). About 79% of aGSU produc-
ing cells are marked and most thyrotropes and gonado-
tropes were marked. EYFP IHC was detected in cells
positive for TSHb (96%), LHb (67%) and FSHb (91%).
Less than 10% of cells positive for other hormones
express EYFP: ACTH (8%), GH (6%) or PRL (7%). This
may not represent ectopic expression because aGSU is
detectable in a variety of pituitary cell types (Childs,
1991; Saeger et al., 2007; Seuntjens et al., 2002).
In summary, we have generated an improved aGSU-
iCre transgenic mouse using BAC recombineering.
Compared to the original aGSU-cre transgenic mouse,
the new line mediates recombination in the pituitary
FIG. 3. Tg(aGSU-iCre) transgene is active primarily in the pituitary gland. Analysis of cre activity in adult tissues was examined by X-Gal
staining of aGSU-iCre;Rosa26LacZ double transgenic mice. Cryo sections were counterstained with neutral red. For the ovary, Tg(aGSU-
iCre) mice were crossed with the double-fluorescent cre reporter mTmG line, that expresses membrane targeted tandem dimer tomato
(mT) prior to cre mediated excision and membrane targeted green fluorescent protein (mG) after excision (Muzumdar et al., 2007). Ovary
sections were counterstained with DAPI (blue). All magnification bars represent 100 mm.
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thyrotropes and gonadotropes, without broad expres-
sion in other pituitary cell types and without ectopic
recombination in the heart, skeletal muscle, and other
ectopic sites characteristic of the original line. It is
tempting to speculate that the evolutionarily conserved
noncoding sequence located 3’ of the aGSU gene could
have a role in generating appropriate tissue specific,
developmentally regulated and cell specific expression,
similar to 3’ regulatory elements that have been identi-
fied for many genes (Antoniou et al., 1988). BAC recom-
bineered transgenes can be an effective and efficient
approach to developing cre strains because identifica-
tion of all the regulatory elements for accurate gene
expression can be tedious, and because knock-in alleles
can create haploinsufficiency for the endogenous gene
and influence the phenotype.
METHODS
BAC Transgene Construction
BAC clone RP24–329P6 containing mouse Cga was
obtained from the BACPAC Resource Center (Oakland,
California). The iCre clone was a kind gift of R. Sprengel
(Shimshek et al., 2002). To place iCre under the control
of Cga, the loxP recombinase site in the pTARBAC1 BAC
cloning vector (Zeng et al., 2001) was replaced with an
amp resistance cassette from the pTAMP plasmid as
FIG. 4. Expression of the BAC Tg(aGSU-iCre) transgene in the adult pituitary gland. aGSU-iCre; Rosa26-EYFP double transgenic mouse
reveals a high level of the aGSU-iCre activity in the anterior lobe of the pituitary, with no expression in the intermediate and posterior lobe.
Panel A: Pituitary cryo section of a aGSU-iCre; Rosa26-EYFP double transgenic mouse stained with EGFP antibody. Panel B: Double immu-
nohistochemistry analysis with antibody against EGFP (green) and aGSU (red) in pituitary cryosections from aGSU-iCre; Rosa26-EYFP
mice. Cell nuclei were stained with DAPI (blue). A, anterior lobe; I, intermediate lobe; P, posterior lobe.
FIG. 5. Tg(aGSU-iCre) is specific for thyrotropes and gonadotropes. Adult pituitary cryo sections from mice doubly transgenic for
Tg(aGSU-iCre) and Rosa26EYFP reporter strain were stained by double immunohistochemistry with antibodies against EYFP (green) and
each pituitary hormone (red). EYFP expression colocalizes with LHb, FSHb, and TSHb in pituitaries from aGSU-iCre; Rosa26-EYFP double
transgenic mice; and not with ACTH, PRL, and GH. Cell nuclei were stained with DAPI (blue).
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described (Lee et al., 2001). A plasmid with an R6K ori-
gin of replication containing iCre (nucleotides 1–1056)
and an FRT-gb2-kan-FRT cassette was assembled in Pir1
bacteria. To introduce iCre, a 100 bp oligonucleotide
was synthesized with 20 bp of homology to the iCre cas-
sette and 80 bp homology immediately downstream of
Cga exon 2 (ENSMUSE00000177972) nucleotide 97.
This primer replaced the Cga initiator methionine with
the initiator methionine of iCre. A second 100 bp oligo
was synthesized that contained 80 bp homology that
began with intron 2 nucleotide 10 and 20 bp of homol-
ogy with the iCre cassette. The oligos were used to PCR
amplify the iCre-FRT-gb2-kan-FRT cassette from the
donor plasmid. The PCR product was used to introduce
the iCre-FRT-gb2-kan-FRT cassette into Cga exon 2 of
the BAC as described above. FLPe was used to excise the
FRT flanked drug selection cassette from the BAC (Lee et
al., 2001). Recombineered BACs were identified by
pulsed field restriction enzyme mapping as described
(Van Keuren et al., 2009). The critical region of the BAC
was completely sequenced after PCR amplifying the Cga
exon 2 iCre knock-in region. Primers used to amplify the
iCre-FRT-gb2-kan-FRT cassette were: Primer 1, which
aligns to vector backbone and Cga: 50 TGAAAGACGGTA
GAAAGGAACTAA TCATTATTGATG TGCATCTAGAAA
CTTGTTTCCCTT TTCATGGCAAGC CTGAGCTTATAT
ACGAAGTTATAA GCTT 30 and Primer 2, which aligns to
iCre and Cga: 50 ACAGCTGGCTTG GGTTATGACTGG
TAAGCTAAGATT ACACTGTTATTA TTTTTTTTTTCA
TGTGCAGCTTGC AGAAGAGCTATG GTGCCCAAGAAG
AAGA 30, with a product size of 2330 bp.
Generation and Genotyping of Transgenic Mice
All experiments using mice were approved by the
University of Michigan Committee on Use and Care of
Animals. The engineered BAC (aGSU-iCre) was injected
into the pronuclei of fertilized eggs from a C57BL/6J
cross with B6D2F1 mice and the fertilized eggs were
transferred into pseudopregnant foster mothers. Trans-
gene positive progeny were genotyped using PCR
amplification of genomic DNA with primers that flank
the junction of the aGSU promoter and the inserted
iCre coding sequence: 50-TGAAGCCATCTCTCTGAGC
AA-30 and 50- CACAGTCAGCAGGTTGGAGA-30, under
the following conditions: 92C for 2 min, followed by
30 cycles of 92C for 10 s, 57C for 30 s and 72C for 30
s, and a final 10 min extension at 72C. Transgene posi-
tive progeny were also genotyped using primers spe-
cific for the chloramphenicol resistance gene located in
the BAC backbone to identify mice that harbor the com-
plete BAC: 50-TCACTACCGGGCGTATTTTT-30 and 50-
GCCGGATAAAACTTGTGCTT-30 and the same PCR
cycling conditions.
B6;129S4-Gt(ROSA)26Sortm1Sor/J, B6.Cg-Gt(ROSA)26
Sortm2(CAG-EYFP)Hze/J, and Gt(ROSA)26Sortm4(ACTB-td
Tomato,-EGFP)Luo/J reporter mice are all available from
The Jackson Laboratory, and were maintained as
homozygotes.
In all the experiments, animals carried one allele of
the cre transgene and one allele of the reporter gene,
whereas controls were negative for the cre transgene
but positive for a reporter gene.
Histology and Immunohistochemistry
Adult tissues and embryos were collected and fixed
for 1 h in 4% formaldehyde in PBS. For embryos, noon
of the day of the vaginal plug is designated as embry-
onic day 0.5. X-gal staining was performed as previously
described (Brinkmeier et al., 1998). After staining,
embryos and adult organs were embedded in OCT
(Sakura Finetek Co., Torrance, CA), and cryosectioned
at 16 mm thickness. Cryosections were counterstained
for 2 min with 1% neutral red stain plus 4% sodium ace-
tate: glacial acetic acid. Sections were mounted with
xylene:permount 1:2 (Fisher) mounting media.
Immunohistochemistry for GFP and hormones was
performed on 16 mm pituitary cryosections. Frozen
pituitary sections were fixed for 5 min in 4% formalde-
hyde and rinsed in 13 PBS. Immunostaining was per-
formed using a goat polyclonal anti-GFP (Abcam)
antibody overnight at 4C, diluted 1:1000 in a blocking
solution comprised of 3% normal donkey serum, 1%
BSA, and 0.5% Triton-X100 in 13 PBS. Slides were
washed three times for 5 min in 13 PBS, followed by 1
h incubation with biotinylated anti-goat secondary anti-
body (Jackson Immunoresearch). Streptavidin-Alexa
488 (Invitrogen) was added for 1 h at 1:100 dilution in
13 PBS. Immunostaining for the different hormones
was carried out with antibodies against each of the pitu-
itary hormones: rabbit anti-aGSU (1:50), guinea pig
anti-LHb (1:100), rabbit anti-FSHb (1:50), rabbit anti-
TSHb (1:200), rabbit anti recombinant PRL (1:200),
monkey anti-GH (1:500), and rabbit anti-ACTH (1:150)
(National Hormone and Pituitary Program, NIDKK).
Table 1
Anterior Pituitary Cell Specificity of Tg:aGSU-iCre Activity
Hormonea
Hormone producing cells
that express EYFP (%)b
aGSU 796 5c
TSHb 966 3c
LHb 676 6c
FSHb 916 4c
ACTH 86 0.2#
PRL 66 0.9#
GH 56 0.5#
aImmunohistochemistry performed with antibodies specific to
the indicated hormone.
bThe data shown represent the mean 1 SEM of three mice per
hormone, counting approximately 500 cells for each pituitary hor-
mone tested.
cDifferent from #, P<0.05.
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Secondary detection was performed as described above
using biotinylated anti-rabbit or anti-guinea antibody
(Vector Laboratories) and streptavidin-Cy3 (Jackson
Immunoresearch), then washed in PBS and mounted
with fluorescent mounting media and images were cap-
tured using a Retiga 2000R camera mounted on a Leica
DMRB fluorescent microscope.
The aGSU-iCre mice will be available upon request.
We recommend using them as hemizygotes since we
evaluated a total of 45 mice borne from a cross of two
hemizygous carriers, and none of them were homozy-
gous; suggesting that homozygosity for the transgene is
lethal.
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